Abstract P27: Proteogenomic and metabolomic analysis of acute myeloid leukemia reveals molecular and functional underpinnings of cellular and clinical phenotypes
Alec Chu(University of Michigan), Marcin Cieślik(University of Michigan), Elie Traer(Memorial Sloan Kettering Cancer Center), Leanne E. Henry(University of Michigan), Gilbert S. Omenn(University of Michigan), Fengchao Yu(University of Michigan), Camilo Posso(Pacific Northwest National Laboratory), Jennifer Kyle(Pacific Northwest National Laboratory), Tao Liu(United States Air Force), James C. Pino(Pacific Northwest National Laboratory), Ginny Li(University of Michigan), Jeffrey Tyner(Oregon Health & Science University), Mamie Lih(Johns Hopkins University), Yamei Deng(University of Michigan), Yongchao Dou(Baylor College of Medicine), Sara J.C. Gosline(Pacific Northwest National Laboratory), Alexey I. Nesvizhskii(University of Michigan), Saravana M. Dhanasekaran(University of Michigan), Hui Zhang(Johns Hopkins University), Bing Zhang(Baylor Genetics), Lijun Chen(Chinese Academy of Medical Sciences & Peking Union Medical College), Chandan Kumar‐Sinha(Indira Gandhi Institute of Medical Sciences), Li Ding(Shenyang Agricultural University), Chenwei Wang(Baylor College of Medicine), Yifat Geffen(Broad Institute), Yi Hsiao(University of Michigan), Arul M. Chinnaiyan(University of Michigan)
Cited by 0
Related Papers
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
|New England Journal of Medicine|2018|1.4k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k